We are continuing to study the structural and genetic basis for generating the diversity of neuropeptide/neurotransmitter phenotypes found in the nervous and endocrine systems. This work involves I) analysis of cis- acting elements determining cell-specific expression and regulation of neuropeptide genes and II) characterization of components of neuropeptide/neurotransmitter vesicles responsible for packaging of neurotransmitters and neuropeptides in neuroendocrine cells. 1) Enkephalin gene regulation in chromaffin cells by protein kinases C and A, and by calcium, and galanin gene regulation in chromaffin cells appear to be mediated by proteins that bind specific sequences within the enkephalin and galanin gene promoters, and that can also be bound by AP-1 consensus motifs, but behave differently from the proteins fos and jun which commonly bind these DNA regulatory motifs in other endocrine and non- endocrine cells. 2) Second messenger signalling pathways appear to act combinatorially to allow difference ratios of neuropeptides to be expressed in chromaffin cells, and this type of regulation may provide an explanation for the many combinations of neuropeptide co-expression seen throughout the neuroendocrine system. 3) Mutational analysis of the vesicular catecholamine transporter has been initiated to determine the structural basis for biogenic amine uptake, and the subsequent biogenic amine transmitter phenotype of cells expressing various members of the biogenic amine vesicular transporter protein family. 4 Chromogranin A, a component of neuropeptide-containing secretory vesicles has been found to be expressed in virtually all neuronal cells of the central and peripheral nervous systems, implying a generalized role for this protein in neuropeptide-containing neuroendocrine cells. The discovery of chromogranin in non-endocrine secretory cells, such as keratinocytes of the skin, suggest that the role of chromogranin A in peptide/protein secretion may be even more general that previously envisioned.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Intramural Research (Z01)
Project #
1Z01MH002386-07
Application #
3781394
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
U.S. National Institute of Mental Health
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Emery, Andrew C; Xu, Wenqin; Eiden, Maribeth V et al. (2017) Guanine nucleotide exchange factor Epac2-dependent activation of the GTP-binding protein Rap2A mediates cAMP-dependent growth arrest in neuroendocrine cells. J Biol Chem 292:12220-12231
Emery, Andrew C; Alvarez, Ryan A; Eiden, Maribeth V et al. (2017) Differential Pharmacophore Definition of the cAMP Binding Sites of Neuritogenic cAMP Sensor-Rapgef2, Protein Kinase A, and Exchange Protein Activated by cAMP in Neuroendocrine Cells Using an Adenine-Based Scaffold. ACS Chem Neurosci 8:1500-1509
Jenkins, Danielle E; Sreenivasan, Dharshini; Carman, Fiona et al. (2016) Interleukin-6-mediated signaling in adrenal medullary chromaffin cells. J Neurochem 139:1138-1150
Jiang, Sunny Zhihong; Eiden, Lee E (2016) Activation of the HPA axis and depression of feeding behavior induced by restraint stress are separately regulated by PACAPergic neurotransmission in the mouse. Stress 19:374-82
Emery, Andrew C; Alvarez, Ryan A; Abboud, Philip et al. (2016) C-terminal amidation of PACAP-38 and PACAP-27 is dispensable for biological activity at the PAC1 receptor. Peptides 79:39-48
Schütz, Burkhard; Schäfer, Martin K-H; Gördes, Markus et al. (2015) Satb2-independent acquisition of the cholinergic sudomotor phenotype in rodents. Cell Mol Neurobiol 35:205-16
Mustafa, Tomris (2013) Pituitary adenylate cyclase-activating polypeptide (PACAP): a master regulator in central and peripheral stress responses. Adv Pharmacol 68:445-57
Samal, Babru; Ait-Ali, Djida; Bunn, Stephen et al. (2013) Discrete signal transduction pathway utilization by a neuropeptide (PACAP) and a cytokine (TNF-alpha) first messenger in chromaffin cells, inferred from coupled transcriptome-promoter analysis of regulated gene cohorts. Peptides 45:48-60
Schäfer, M K-H; Hartwig, N R; Kalmbach, N et al. (2013) Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models. Diabetologia 56:1047-56
Naudé, Petrus J W; Nyakas, Csaba; Eiden, Lee E et al. (2012) Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J 26:2811-23

Showing the most recent 10 out of 70 publications